These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 617295)

  • 41. [Acute changes of the mechanical function of the ischaemic left ventricle by sublingual nifedipine (author's transl)].
    Trevi GP; Sheiban I; Benussi P; Dal Forno P; Marini A; Poppi A
    G Ital Cardiol; 1980; 10(4):424-30. PubMed ID: 7439583
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antianginal drug effects on normal, ischemic and scar myocardial segments in man.
    Pfisterer M; Fridrich R; Burkart F
    Scand J Clin Lab Invest Suppl; 1984; 173():65-73. PubMed ID: 6442004
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Left ventricular response to exercise in patients with coronary artery disease and the effects of nifedipine].
    Shen WF; Gong LS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1987 Apr; 15(2):86-8, 127. PubMed ID: 3622262
    [No Abstract]   [Full Text] [Related]  

  • 44. [The effect of nifedipine on the pulmonary artery pressure in patients with coronary heart disease (author's transl)].
    Beck OA; Hochrein H
    Med Klin; 1978 Mar; 73(13):457-62. PubMed ID: 634205
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Conservative therapy of angina pectoris using nifedipine (Adalat)].
    Hagel FK
    Fortschr Med; 1975 Aug; 93(24):1118-22. PubMed ID: 818001
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effects of diagitalis on the behavior of systolic time intervals (STI) during atrial electrostimulation (AE) in subjects with ischemic cardiopathy].
    De Caprio L; Rengo F; Bonaduce D; Piscione F; Scarafile P; Carlomango A; Ferro G; Petretta M
    Boll Soc Ital Cardiol; 1977; 22(10):1843-53. PubMed ID: 753316
    [No Abstract]   [Full Text] [Related]  

  • 47. Nifedipine therapy for coronary vasospasm.
    Stone PH; Antman EM; Muller JE
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():137-42. PubMed ID: 6407436
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical trial of nifedipine in ischemic cardiopathy. Comparison of the traditional evaluation and effects on cardiac metabolism].
    Mattioli G; Nardini M; Zennaro RG
    Boll Soc Ital Cardiol; 1978; 23(8):1414-23. PubMed ID: 232986
    [No Abstract]   [Full Text] [Related]  

  • 49. [Comparative studies on perhexiline, nifedipine and practolol in the light of spirometric and ergometric examinations].
    Adamska-Dyniewska H; Dziekański S
    Kardiol Pol; 1978; 21(1):13-20. PubMed ID: 651111
    [No Abstract]   [Full Text] [Related]  

  • 50. [Results of a field trial of the coronary drug Adalat (BAY a 1040)].
    Dünschede HB; Grundei P
    Med Welt; 1975 Oct; 26(40):1847-50. PubMed ID: 1102835
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of oxyfedrine on exercise performance and systolic time intervals in patients of angina pectoris.
    Puri VK; Agarwal SK; Mehrotra A; Hasan M
    Indian Heart J; 1984; 36(4):226-30. PubMed ID: 6389320
    [No Abstract]   [Full Text] [Related]  

  • 52. Comparative effects of captopril and nifedipine on diastolic and systolic cardiac function in elderly hypertensive patients.
    Marmor A; Traub Y; Churi A; Troshar D; Schneeweiss A
    J Hypertens Suppl; 1988 Nov; 6(1):S101-3. PubMed ID: 3063782
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Double-blind trial of nifedipine in angina patients with normal coronary arteries.
    Pitcher D; Sowton E
    Pharmatherapeutica; 1981; 3(1):6-13. PubMed ID: 6798584
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term preservation of left ventricular function in medically treated patients with coronary artery disease and persistent exercise-induced ischemia.
    Fragasso G; Xuereb RG; Xuereb M; Rossetti E; Margonato A; Chierchia SL
    Cardiologia; 1999 Mar; 44(3):255-60. PubMed ID: 10327727
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effects of sublingual isosorbide dinitrate on systolic time intervals in normal subjects and those with coronary disease].
    Paterna S; Campisi D; Bivona A; Valenza M; Di Maso N; Alaimo V
    Boll Soc Ital Biol Sper; 1984 Jan; 60(1):29-35. PubMed ID: 6704251
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment of spontaneous and effort angina with nifedipine].
    Valle Tudela V; Alijarde Guimera M; Cortadellas Angel MJ; Ríus Garriga J; Soler Soler J
    Rev Esp Cardiol; 1982; 35(5 Suppl 2):II53-60. PubMed ID: 7170408
    [No Abstract]   [Full Text] [Related]  

  • 57. [The ergometric test in the evaluation of the effects of nifedipine, verapamil and ethyl cinepazat maleate in angina of effort].
    Novo S; Davì G; Riolo F; Pinto A; Avellone G; Fazio M
    Boll Soc Ital Cardiol; 1980; 25(2):139-48. PubMed ID: 7236439
    [No Abstract]   [Full Text] [Related]  

  • 58. [Use and advantages of a new method of determining systolic time intervals in a variety of cardiocirculatory stress situations].
    Ferro G; Santinelli V; Tari MG; Vitale D; Chiariello M; Condorelli M
    Boll Soc Ital Cardiol; 1978; 23(6):1021-7. PubMed ID: 261868
    [No Abstract]   [Full Text] [Related]  

  • 59. [Systolic time intervals and the determination of cardiac performance].
    Kozák P
    Vnitr Lek; 1980; 26(5):470-7. PubMed ID: 7395121
    [No Abstract]   [Full Text] [Related]  

  • 60. [Evaluation of nifedipine treatment in angina at rest].
    Bobba P; Previtali M; Salerno JA
    Rev Esp Cardiol; 1982; 35(5 Suppl 2):II33-6. PubMed ID: 7170406
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.